Commercial
Advanced Search
  
MPNewsFlashTopicPub
MPPurposePub
  
  
  
  
1/20/2023
Coverage of the COVID-19 Vaccination for Independence Commercial Members (Retroactively effective to December 8, 2022. Updated January 20, 2023)
This policy communication,​ addressing COVID-19 vaccine for Independence Commercial members, replaces the version that was issued on November 2, 2022. The following procedure codes have been added to this document in accordance with the FDA Emergency Use Authorization (EUA). These codes are retroactively effective to December 8, 202291316, 0164A, 91317, 0173A.

0.1Coverage of the COVID-19 Vaccination for Independence Commercial Members (Retroactively effective to December 8, 2022. Updated January 20, 2023)e1502553-a927-4216-a857-108dbad3ad32
12/30/2022
01/01/2023 CPT and HCPCS Quarterly Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 01/01/2023, unless otherwise noted. For more information related to these services, please refer to specific policies when applicable.​​​​​​​

0.101/01/2023 CPT and HCPCS Quarterly Update Coverage Determinations for Commercial Products1eb0d681-00a1-4f46-a5c0-cc84b4e3ade7
12/15/2022
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Commercial Members (Updated December 15, 2022)

The purpose of this communication is to provide notice regarding information and procedure codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence commercial members. Additionally, this Company document identifies when coverage is provided for clinical purposes, and the Misspelled Wordnonco​vered instances such as public health surveillance & screening. 

​​


0.1Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Commercial Members (Updated December 15, 2022)86f386e1-3f40-4bcd-801f-56c8b6060984
11/7/2022
Laboratory Testing, Vaccination, and Treatment for Monkeypox for Independence Commercial Members (Updated November 7, 2022)
The purpose of this document is to communicate the Company's coverage positions for laboratory testing, vaccination, and treatment for monkeypox.
0.1Laboratory Testing, Vaccination, and Treatment for Monkeypox for Independence Commercial Members (Updated November 7, 2022)b5760d4e-45de-4375-86b8-6216d6cd050c
10/31/2022
Expanded Preventive Coverage of Pneumococcal 15-valent Conjugate Vaccine for Independence Commercial Members (Retroactively Effective 06/22/2022)
The purpose of this document is to provide notice regarding the expanded preventive​ coverage of pneumococcal 15-valent conjugate vaccine​ for our Independence Commercial members.
0.1Expanded Preventive Coverage of Pneumococcal 15-valent Conjugate Vaccine for Independence Commercial Members (Retroactively Effective 06/22/2022)2af4994c-002a-49d5-952c-4cf479278807
6/29/2022
07/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 07/01/2022, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​​​​​​​

007/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products7ecadee4-3722-4789-8ebe-7f88897f0396
6/14/2022
Preventive Coverage of Colonoscopy Following a Positive Non-invasive Stool-based Screening Test or Direct Visualization Test for Independence Commercial Members
The purpose of this communication is to convey our current coverage position regarding coverage of a screening colonoscopy following a positive non-invasive stool-based screening test or direct visualization test for Independence Commercial members. 

0.1Preventive Coverage of Colonoscopy Following a Positive Non-invasive Stool-based Screening Test or Direct Visualization Test for Independence Commercial Members8e53383e-514d-4558-8868-d69787ca978a
5/31/2022
Preventive Coverage of FDA-Approved Contraceptive Mobile Applications for Independence Commercial Members
The purpose of this communication is to provide notice regarding the preventive coverage of FDA-approved contraceptive mobile applications​​ for Independence Commercial members effective June 1, 2022. 
0.1Preventive Coverage of FDA-Approved Contraceptive Mobile Applications for Independence Commercial Membersa9a84ad3-aaa7-45ce-b785-63633b8906bb
3/31/2022
04/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Medicare Advantage Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 04/01/2022, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​​​​​​


0.104/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products00fd5da3-c5a3-4c49-adf1-5405e7136e9a
3/7/2022
Preventive Coverage of Recombinant zoster vaccine (Shingrix), 15-Valent Pneumococcal Conjugate Vaccine, and 20-Valent Pneumococcal Conjugate Vaccine for Independence Commercial Members
The purpose of this communication is to provide notice regarding the expanded preventive coverage criteria for recombinant zoster vaccine (Shingrix), 15-Valent Pneumococcal Conjugate Vaccine, and 20-Valent Pneumococcal Conjugate Vaccine​​​ for Independence Commercial members effective January 21, 2022.

0.1Preventive Coverage of Recombinant zoster vaccine (Shingrix), 15-Valent Pneumococcal Conjugate Vaccine, and 20-Valent Pneumococcal Conjugate Vaccine for Independence Commercial Membersdd4ceef2-2beb-45cd-9523-7be482ca7a88
12/31/2021
Coverage of Speech Therapy Services Performed Through Telemedicine for Independence Commercial Members (Updated January 1, 2022)

The purpose of this communication is to provide notice regarding coverage for speech therapy services performed through telemedicine for our Independence Commercial members during the coronavirus disease 2019 public health emergency.

0.1Coverage of Speech Therapy Services Performed Through Telemedicine for Independence Commercial Members (Updated January 1, 2022) e1cfa675-fd30-49d8-8ebe-5516fbbac4da
12/31/2021
1/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products (Updated January 7, 2022)
The intent of this document ​is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 01/01/2022, unless otherwise noted.
0.11/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products (Updated January 7, 2022)5b4a4df3-2ec7-47ba-b80b-226612429235
10/1/2021
10/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 10/1/2021, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​​​​​

0.110/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products490ecf35-0761-440c-b534-a035b758d9eb
4/1/2021
4/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 4/1/2021, unless otherwise noted.


0.14/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Productsc832c919-e231-49f5-b0dc-09bc2f5e33b7
1/4/2021
1/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Commercial Product coverage determinations for services identified through the Annual Code Update process. 
01/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Productsb976b7b6-ff87-4f04-a559-d2f8805e0586
10/22/2020
Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Commercial Members (Retroactively effective to November 8, 2022, issued January 30, 2023)
The purpose of this document is to communicate the Company's coverage position for Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Commercial members. 

0.1Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Commercial Members (Retroactively effective to November 8, 2022, issued January 30, 2023)408fab84-e769-4ad9-8534-1e2c16cad9a4
4/29/2020
Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (December 15, 2021)
The purpose of this News Article is to provide advance notice regarding direct supervision requirements for Incident to services performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in response to Coronavirus Disease 2019 (COVID-19).
1Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (December 15, 2021)CC0B8A7BBD74419185258558007CCF61